TABLE 2.
Personal medical histories of patients with meningiomas and controls*
| No. of Individuals (%) |
|||
|---|---|---|---|
| Factor | Patients | Controls | OR (95% CI)† |
| no. of cases | 1124 | 1000 | |
| cancer | |||
| females only | |||
| breast cancer‡ | 41 (5.0) | 25 (3.7) | 1.4 (0.8–2.3) |
| ovarian cancer | 2 (0.2) | 1 (0.1) | 1.6 (0.2–18.3)§ |
| endometrial cancer | 10 (1.2) | 6 (0.9) | 1.4 (0.5–3.8) |
| cervical cancer | 6 (0.7) | 7 (1.0) | 0.7 (0.2–2.1) |
| uterine fibroids | 239 (29.4) | 172 (25.6) | 1.2 (1.0–1.5) |
| endometriosis | 115 (14.2) | 66 (9.8) | 1.5 (1.1–2.1) |
| males only | |||
| prostate | 13 (4.4) | 18 (5.7) | 0.6 (0.3–1.4) |
| males & females | |||
| lung cancer | 5 (0.4) | 2 (0.2) | 2.1 (0.4–11.1) |
| colon cancer | 0 (0) | 1 (0.2) | NA |
| melanoma | 18 (1.6) | 20 (2.0) | 0.8 (0.4–1.5) |
| glioma | 0 (0) | 0 (0) | NA |
| leukemia | 10 (0.9) | 2 (0.2) | 4.7 (1.0–21.5) |
| thyroid cancer | 12 (1.1) | 2 (0.2) | 5.4 (1.2–24.1) |
| vascular disease | |||
| myocardial infarction | 42 (4.2) | 43 (3.9) | 0.9 (0.6–1.4) |
| stroke | 27 (2.7) | 37 (3.3) | 1.2 (0.7–2.0) |
| IDDM | 21 (2.1) | 41 (3.7) | 1.8 (1.0–3.0) |
| NIDDM | 83 (8.3) | 110 (9.9) | 1.2 (0.9–1.6) |
| immune dysfunction | |||
| allergy | 259 (23.2) | 329 (33) | 0.6 (0.5–0.7) |
| chicken pox | 926 (87.9) | 881 (92) | 0.6 (0.5–0.8) |
| shingles | 121 (10.9) | 128 (12.9) | 0.8 (0.6–1.05) |
| asthma | 144 (12.9) | 174 (17.4) | 0.7 (0.6–0.9) |
| eczema | 100 (9) | 109 (11) | 0.8 (0.6–1.1) |
| other | |||
| NF1 | 1 (0.1) | 0 (0) | NA |
| NF2 | 5 (0.6) | 0 (0) | NA |
| depression | 284 (26.7) | 237 (26.1) | 1.0 (0.8–1.2) |
| seizure | 44 (4.0) | 20 (2.2) | 1.7 (1.0–2.9) |
*
Bolded values indicate significance. Abbreviations: IDDM = insulin-dependent diabetes mellitus; NA = not applicable; NIDDM = non–insulin-dependent diabetes mellitus.
†
Adjusted for age and sex.
‡
No men with breast cancer were reported.
§
Fisher exact test.